AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
First Sucanon production order completed.
2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Robert Rieveley, president of Biotech Holdings (BIO.V; BIOHF) announced that the company has completed the first production order of its Sucanon diabetes drug.
"I am pleased to report that our first production order is now completed. We have manufactured Sucanon for 1.2 million tablets or 20,000 1-month treatment packages. We project shipping this production to Mexico this week," Rieveley said.
"The sales value to Biotech of this shipment is in the range of $240,000 U.S.," Rieveley said.
"Monthly shipments of this volume, providing monthly treatment for 20,000 diabetics, would move us easily into profitability. With 10 million reporting Type II diabetics in Mexico and 10 million unreporting, we believe that Mexico offers tremendous potential for ongoing use of Sucanon as an effective and very safe treatment of type II diabetes symptoms. Our plant capacity of up to 400,000 1-month treatment packages can be readily expanded as needed," ...
- Biotech Holdings private placement funding to be applied to diabetes drug...
- Newspaper article from: Biotech Business Week November 22, 2004 700+ words
...Rieveley, president of Biotech Holdings (BIO.V; BIOHF...number of diabetics. Biotech Holdings has received regulatory...prepared by Biotech Business Week editors from staff...Copyright 2004, Biotech Business Week via NewsRx.com...
- Biotech Holdings expands distribution of its Sucanon Type II diabetes drug in...
- Press release article from: PR Newswire May 30, 2007 700+ words
...30 /PRNewswire-FirstCall/ -- Biotech Holdings (the "Company", TSXV: BIO; OTC...The private company, unrelated to Biotech Holdings, focuses on sales of antibiotic products...revenue growth in these new markets, Biotech Holdings will transfer to the Colombian company...
- Biotech Holdings begins investor awareness program for fall period.
- Press release article from: PR Newswire August 27, 2004 700+ words
Biotech Holdings (the "Company", BIOHF.OB...its investor awareness program for Biotech Holdings. "We are pleased to be working...com/stockhouse/bio2.wax Biotech Holdings' Sucanon is a new drug for treatment...
- Biotech Holdings closes additional private placement funding.
- Press release article from: PR Newswire February 27, 2004 700+ words
Robert Rieveley, President of Biotech Holdings (the "Company", TSX-VEN: BIO...warrants expire at 24 months from issue. Biotech Holdings' key product is a novel new drug...Diabetes and Impaired Glucose Tolerance. Biotech Holdings has received regulatory approval for...
- Biotech Holdings signs Sucanon Marketing agreement for Mexico.
- Press release article from: PR Newswire June 1, 2004 700+ words
Robert Rieveley, President of Biotech Holdings (the "Company", TSX-V: BIO...Sucanon," Mr. Rieveley added. Biotech Holdings' Sucanon is an insulin-sensitizing...that controls blood sugar levels. Biotech Holdings has received regulatory approval for...
- Biotech Holdings leases facilities, acquires equipment for Sucanon drug...
- Press release article from: PR Newswire January 28, 2004 700+ words
Robert Rieveley, President of Biotech Holdings (the "Company", BIOHF.OB: OB...marketers," Mr. Rieveley said. Biotech Holdings' key product is a novel new drug...Diabetes and Impaired Glucose Tolerance. Biotech Holdings has received regulatory approval for...
- Biotech Holdings makes first shipment of Sucanon diabetes drug.
- Press release article from: PR Newswire May 3, 2004 700+ words
Robert Rieveley, President of Biotech Holdings (the "Company", TSX-V: BIO...than 18 million in North America. Biotech Holdings' Sucanon is an insulin-sensitizing...that controls blood sugar levels. Biotech Holdings has received regulatory approval for...
- Biotech Holdings Sucanon drug facility on schedule for completion.
- Press release article from: PR Newswire March 19, 2004 700+ words
Robert Rieveley, President of Biotech Holdings (the "Company", TSX-VEN: BIO...marketing plans," Mr. Rieveley said. Biotech Holdings' Sucanon is a new drug for treatment...America and over 150 million worldwide. Biotech Holdings has received regulatory approval for...